Increased Number of Circulating Progenitor Cells After Implantation of Ventricular Assist Devices

Journal of Heart and Lung Transplantation

Volumn 28, Issue 7, 2009, Pages 710-717

  Manginas, Athanassios ^a   Tsiavou, Anastasia ^a   Sfyrakis, Petros ^a   Giamouzis, Gregory ^a   Tsourelis, Loukas ^a   Leontiadis, Evangelos ^a   Degiannis, Dimitrios ^a   Cokkinos, Dennis V ^a   Alivizatos, Petros A ^a  

^a ONASSIS CARDIAC SURGERY CENTER   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN NATRIURETIC PEPTIDE; CD133 ANTIGEN; CD133 MONOCLONAL ANTIBODY; CD34 ANTIBODY; CD34 ANTIGEN; GRANULOCYTE COLONY STIMULATING FACTOR; INTERLEUKIN 8; MONOCLONAL ANTIBODY; UNCLASSIFIED DRUG; VASCULAR ENDOTHELIAL GROWTH FACTOR ALPHA; VASCULOTROPIN; VASCULOTROPIN ANTIBODY; VASCULOTROPIN RECEPTOR 2;

ADULT; ANTIGEN EXPRESSION; ARTICLE; BLOOD; BLOOD SAMPLING; BONE MARROW CELL; CD34 SELECTION; CELL COUNT; CELL KINETICS; CELL MOTILITY; CELL SUBPOPULATION; CLINICAL ARTICLE; CONGESTIVE HEART FAILURE; FLOW CYTOMETRY; HEART ASSIST DEVICE; HUMAN; IMPLANTATION; INTERMETHOD COMPARISON; MALE; PRIORITY JOURNAL; PROTEIN INTERACTION; QUANTITATIVE ANALYSIS; STAINING; STEM CELL;

ADULT; AGED; ANTIGENS, CD; ANTIGENS, CD34; CASE-CONTROL STUDIES; CELL DIFFERENTIATION; CELL PROLIFERATION; GLYCOPROTEINS; GRANULOCYTE COLONY-STIMULATING FACTOR; HEART FAILURE; HEART-ASSIST DEVICES; HEMATOPOIETIC STEM CELLS; HUMANS; INTERLEUKIN-8; MALE; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN; PEPTIDES; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-2;

EID: 67649108897     PISSN: 10532498     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.healun.2009.04.006     Document Type: Article

References (48)

1. Rose E.A., Gelijns A.C., Moskowitz A.J., et al. Long-term mechanical left ventricular assistance for end-stage heart failure. N Engl J Med 345 (2001) 1435-1443
2. Asahara T., Murohara T., Sullivan A., et al. Isolation of putative progenitor endothelial cells for angiogenesis. Science 275 (1997) 964-967
3. Urbich C., Heeschen C., Aicher A., Dernbach E., Zeiher A.M., and Dimmeler S. Relevance of monocytic features for neovascularization capacity of circulating endothelial progenitor cells. Circulation 108 (2003) 2511-2516
4. Urbich C., Aicher A., Heeschen C., et al. Soluble factors released by endothelial progenitor cells promote migration of endothelial cells and cardiac resident progenitor cells. J Mol Cell Cardiol 39 (2005) 733-742
5. Ingram D.A., Caplice N.M., and Yoder M.C. Unresolved questions, changing definitions, and novel paradigms for defining endothelial progenitor cells. Blood 106 (2005) 1525-1531
6. Peichev M., Naiyer A.J., Pereira D., et al. Expression of VEGFR-2 and AC133 by circulating human CD34(+) cells identifies a population of functional endothelial precursors. Blood 95 (2000) 952-958
7. Urbich C., and Dimmeler S. Endothelial progenitor cells: characterization and role in vascular biology. Circ Res 95 (2004) 343-353
8. Yin A.H., Miraglia S., Zanjani E.D., et al. AC133, a novel marker for human hematopoietic stem and progenitor cells. Blood 90 (1997) 5002-5012
9. Laufs U., Werner N., Link A., et al. Physical training increases endothelial progenitor cells, inhibits neointima formation, and enhances angiogenesis. Circulation 109 (2004) 220-226
10. Wojciech W., RataJczak M., and Tendera M. Intereukin-8:more on the mechanisms of progenitor cells mobilization in acute coronary syndromes. Eur Heart J 27 (2006) 1013-1015
11. Leone A.M., Rutella S., Bonanno G., et al. Endogenous G-CSF and CD34+ cell mobilization after acute myocardial infarction. Int J Cardiol 111 (2006) 202-208
12. Asahara T., Takahashi T., Masuda H., et al. VEGF contributes to postnatal neovascularization by mobilizing bone marrow-derived endothelial progenitor cells. EMBO J 18 (1999) 3964-3972
13. George J., Goldstein E., Abashidze A., et al. Erythropoietin promotes endothelial progenitor cell proliferative and adhesive properties in a PI 3-kinase-dependent manner. Cardiovasc Res 68 (2005) 299-306
14. Dimmeler S., Aicher A., Vasa M., et al. HMG-CoA reductase inhibitors (statins) increase endothelial progenitor cells via the PI 3-kinase/Akt pathway. J Clin Invest 108 (2001) 391-397
15. Hill J.M., Zalos G., Halcox J.P., et al. Circulating endothelial progenitor cells, vascular function, and cardiovascular risk. N Engl J Med 348 (2003) 593-600
16. Gill M., Dias S., Hattori K., et al. Vascular trauma induces rapid but transient mobilization of VEGFR2(+)AC133(+) endothelial precursor cells. Circ Res 88 (2001) 167-4
17. Goette A., Jentsch-Ullrich K., Lendeckel U., et al. Effect of atrial fibrillation on hematopoietic progenitor cells: a novel pathophysiological role of the atrial natriuretic peptide?. Circulation 108 (2003) 2446-2449
18. Massa M., Rosti V., Ferrario M., et al. Increased circulating hematopoietic and endothelial progenitor cells in the early phase of acute myocardial infarction. Blood 105 (2005) 199-206
19. Schmidt-Lucke C., Rössig L., Fichtlscherer S., et al. Reduced number of circulating endothelial progenitor cells predicts future cardiovascular events: proof of concept for the clinical importance of endogenous vascular repair. Circulation 111 (2005) 2981-2987
20. Valgimigli M., Rigolin G.M., Fucili A., et al. CD34+ and endothelial progenitor cells in patients with various degrees of CHF. Circulation 110 (2004) 1209-1212
21. Fadini G.P., Coracina A., Baesso I., et al. Peripheral blood CD34+KDR+ endothelial progenitor cells are determinants of subclinical atherosclerosis in a middle-aged general population. Stroke 37 (2006) 2277-2282
22. Bland J.M., and Douglas G.A. Calculating correlation coefficients with repeated observations: Part 2--correlation between subjects. BMJ 310 (1995) 633
23. Rafii S., Oz M.C., Seldomridge J.A., et al. Characterization of hematopoietic cells arising on the textured surface of left ventricular assist devices. Ann Thorac Surg 60 (1995) 1627-1632
24. Iversen P.O., Woldbaek P.R., Tønnessen T., and Christensen G. Decreased hematopoiesis in bone marrow of mice with CHF. Am J Physiol Regul Integr Comp Physiol 282 (2002) R166-R172
25. Nonaka-Sarukawa M., Yamamoto K., Aoki H., et al. Circulating endothelial progenitor cells in CHF. Int J Cardiol 119 (2007) 344-348
26. Hampton C.R., and Verrier E.D. Systemic consequences of ventricular assist devices: alterations of coagulation, immune function, inflammation, and the neuroendocrine system. Artif Organs 26 (2002) 902-908
27. Wohlschlaeger J., Schmitz K.J., Schmid C., et al. Reverse remodeling following insertion of left ventricular assist devices (LVAD): a review of the morphological and molecular changes. Cardiovasc Res 68 (2005) 376-386
28. Jahanyar J., Youker K.A., Torre-Amione G., et al. Increased expression of stem cell factor and its receptor after left ventricular assist device support: a potential novel target for therapeutic interventions in heart failure. J Heart Lung Transplant 27 (2008) 701-709
29. Perin E.C., Dohmann H.F., Borojevic R., et al. Transendocardial, autologous bone marrow cell transplantation for severe, chronic ischemic heart failure. Circulation 107 (2003) 2294-2302
30. Yoshioka T., Ageyama N., Shibata H., et al. Repair of infarcted myocardium mediated by transplanted bone marrow-derived CD34+ stem cells in a nonhuman primate model. Stem Cells 23 (2005) 355-364
31. Assmus B., Schächinger V., Teupe C., et al. Transplantation of Progenitor Cells and Regeneration Enhancement in Acute Myocardial Infarction (TOPCARE-AMI). Circulation 106 (2002) 3009-3017
32. Tse H.F., Kwong Y.L., Chan J.K., Lo G., Ho C.L., and Lau C.P. Angiogenesis in ischaemic myocardium by intramyocardial autologous bone marrow mononuclear cell implantation. Lancet 361 (2003) 47-49
33. Stamm C., Westphal B., Kleine H.D., et al. Autologous bone-marrow stem-cell transplantation for myocardial regeneration. Lancet 361 (2003) 45-46
34. Wollert K.C., Meyer G.P., Lotz J., et al. Intracoronary autologous bone-marrow cell transfer after myocardial infarction: the BOOST randomised controlled clinical trial. Lancet 364 (2004) 141-148
35. Nissen N.N., Polverini P.J., Koch A.E., et al. Vascular endothelial growth factor mediates angiogenic activity during the proliferative phase of wound healing. Am J Pathol 152 (1998) 1445-1452
36. Scheubel R.J., Zorn H., Silber R.E., et al. Age-dependent depression in circulating endothelial progenitor cells in patients undergoing coronary artery bypass grafting. J Am Coll Cardiol 42 (2003) 2073-2080
37. Fadini G.P., de Kreutzenberg S.V., Coracina A., et al. Circulating CD34+ cells, metabolic syndrome, and cardiovascular risk. Eur Heart J 27 (2006) 2247-2255
38. Popa E.R., Harmsen M.C., Tio R.A., et al. Circulating CD34+ progenitor cells modulate host angiogenesis and inflammation in vivo. J Mol Cell Cardiol 41 (2006) 86-96
39. Maisel A.S., Krishnaswamy P., Nowak R.M., et al. Breathing Not Properly Multinational Study Investigators. Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure. N Engl J Med 347 (2002) 161-167
40. Rothenburger M., Wichter T., Schmid C., et al. Aminoterminal pro type B natriuretic peptide as a predictive and prognostic marker in patients with chronic heart failure. J Heart Lung Transplant 23 (2004) 1189-1197
41. Nakagawa O., Ogawa Y., Itoh H., et al. Rapid transcriptional activation and early mRNA turnover of brain natriuretic peptide in cardiocyte hypertrophy. Evidence for brain natriuretic peptide as an "emergency" cardiac hormone against ventricular overload. J Clin Invest 96 (1995) 1280-1287
42. Bruggink A.H., de Jonge N., van Oosterhout M.F., et al. Brain natriuretic peptide is produced both by cardiomyocytes and cells infiltrating the heart in patients with severe heart failure supported by a left ventricular assist device. J Heart Lung Transplant 25 (2006) 174-180
43. Maeda K., Tsutamoto T., Wada A., Hisanaga T., and Kinoshita M. Plasma brain natriuretic peptide as a biochemical marker of high left ventricular end-diastolic pressure in patients with symptomatic left ventricular dysfunction. Am Heart J 135 (1998) 825-832
44. Sodian R., Loebe M., Schmitt C., et al. Decreased plasma concentration of brain natriuretic peptide as a potential indicator of cardiac recovery in patients supported by mechanical circulatory assist systems. J Am Coll Cardiol 38 (2001) 1942-1949
45. Milting H., EL Banayosy A., Kassner A., et al. The time course of natriuretic hormones as plasma markers of myocardial recovery in heart transplant candidates during ventricular assist device support reveals differences among device types. J Heart Lung Transplant 20 (2001) 949-955
46. Kemperman H., van den Berg M., Kirkels H., and de Jonge N. B-type natriuretic peptide (BNP) and N-terminal proBNP in patients with end-stage heart failure supported by a left ventricular assist device. Clin Chem 50 (2004) 1670-1672
47. Heeschen C., Lehmann R., Honold J., et al. Profoundly reduced neovascularization capacity of bone marrow mononuclear cells derived from patients with chronic ischemic heart disease. Circulation 109 (2004) 1615-1622
48. Kissel C.K., Lehmann R., Assmus B., et al. Selective functional exhaustion of hematopoietic progenitor cells in the bone marrow of patients with postinfarction heart failure. J Am Coll Cardiol 49 (2007) 2341-2349